Exploring Multiple Strategic Options: A Multi-Track Process
Sell-Side Forecast & Transaction Structuring Leading to Licensing Deal
David Chacko, Erasca
“The RNA team is responsive and efficient and understands the nuances of valuation as pertains to our sector, and we valued our partnership with them.”
Chris Vasquez, Biodesix
“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”
4DMT
Major Pharma Out-Licensing Deal
Sell-Side Transaction Support for Major Pharmaceutical Company Out-Licensing Deal
Biodesix
Supporting the Entire Life Cycle: Biotech Company
RNA Advisors Supported a Biotech Company from Inception through IPO through M&A
Vera Therapeutics
Cargo Therapeutics
Marshall Fordyce, Vera Therapeutics
“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
